FDA 483 - Alps Pharmaceutical Industrial Co., Ltd. - October 13, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Alps Pharmaceutical Ind. Co., Ltd. in Hida City, Japan, revealed two significant observations regarding laboratory controls. The firm failed to follow its own QC laboratory procedure for synchronizing instrument times, and its microbiological laboratory lacked written procedures for cleaning incubators and properly labeling prepared media. These deficiencies suggest inadequate control over critical laboratory processes for active pharmaceutical ingredients shipped to the US.
ID · c8e4a1c5-ff9c-4e07-a359-22561b15ce13